Related Experiment Videos
Structurally different rat liver medium-chain acyl CoA dehydrogenases directed by complementary DNAs differing in
T Inagaki1, N Ohishi, N Tsukagoshi
1Institute of Applied Biochemistry, Yagi Memorial Park, Gifu, Japan.
Biochimica Et Biophysica Acta
|April 29, 1991
Summary
Different forms of rat liver medium-chain acyl CoA dehydrogenase (MCAD) were produced in E. coli. The study found that the leader peptide and NH2-terminal deletions affect FAD binding and enzyme activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Medium-chain acyl CoA dehydrogenase (MCAD) is crucial for fatty acid metabolism in the liver.
- Understanding MCAD structure-function relationships is vital for metabolic research.
- Expression of functional enzymes in microbial systems facilitates biochemical studies.
Purpose of the Study:
- To investigate the impact of different 5'-cDNA regions on rat liver MCAD expression in E. coli.
- To characterize the enzymatic activity and FAD binding of MCAD variants.
- To elucidate the role of the leader peptide and N-terminus in MCAD function.
Main Methods:
- Recombinant expression of rat liver MCAD variants in Escherichia coli using various plasmids.
- Protein extraction, purification, and homogeneity assessment.
- Enzymatic activity assays and FAD content determination.
Main Results:
- A 44 kDa MCAD protein expressed from pRMCADm-3 exhibited high activity and purified to homogeneity with bound FAD.
- A 45 kDa MCAD protein from pRMCADm-1 lacked FAD and activity, indicating leader peptide interference with FAD binding.
- A 40 kDa MCAD protein from pRMCADm-6 also lacked FAD, suggesting N-terminal deletions impair FAD association.
Conclusions:
- The leader peptide of rat liver MCAD significantly hinders FAD binding.
- N-terminal deletions in the MCAD apoprotein can also compromise FAD association.
- Recombinant expression systems are effective for studying MCAD structure-function relationships and FAD cofactor interactions.